Orchestra BioMed director granted 42,553 stock options
Orchestra BioMed Holdings director Chris Cleary reported compensation-related equity transactions.
Rhea-AI Filing Summary
Orchestra BioMed Holdings director Chris Cleary reported compensation-related equity transactions. On this Form 4, 3,510 shares of common stock were disposed of through share withholding to cover tax obligations tied to vesting of restricted stock units, and no shares were sold in the market. After this tax-withholding disposition, Cleary directly holds 33,391 common shares.
He also received a grant of stock options for 42,553 shares of common stock at an exercise price of $4.04 per share, expiring on June 23, 2036. According to the footnote, these options will vest on the one-year anniversary of June 23, 2026, subject to his continuous service with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Cleary Chris
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock, par value $0.0001 per share | 3,510 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 42,553 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 42,553 contracts (Direct);
Common Stock, par value $0.0001 per share — 33,391 shares (Direct)
Footnotes (2)
- F1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
- F2. The stock options will vest on the one year anniversary of June 23rd, 2026 (the "Grant Date"), subject to the Reporting Person's continuous service through such date.
Key Figures
Tax-withheld shares: 3,510 shares
Shares held after RSU vesting: 33,391 shares
Stock options granted: 42,553 options
+3 more
6 metrics
Tax-withheld shares
3,510 shares
Shares withheld to satisfy RSU tax obligations
Shares held after RSU vesting
33,391 shares
Common stock directly owned after tax-withholding disposition
Stock options granted
42,553 options
New stock option grant to director Chris Cleary
Option exercise price
$4.04 per share
Exercise price of newly granted stock options
Option expiration date
June 23, 2036
Expiration of stock options on common stock
Tax-withholding transactions
3,510 shares
Total shares used for RSU tax withholding per summary
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), tax withholding obligations, Grant Date
4 terms
restricted stock units ("RSUs") financial
"vesting of restricted stock units ("RSUs"). No shares were sold"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
""Stock Option (Right to Buy)" as the derivative security title"
tax withholding obligations financial
"withholding of shares by the Issuer to satisfy tax withholding obligations"
Grant Date financial
"The stock options will vest on the one year anniversary of June 23rd, 2026 (the "Grant Date")"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
FAQ
What insider transactions did OBIO director Chris Cleary report on this Form 4?
Chris Cleary reported two equity-related transactions: a tax-withholding disposition of 3,510 common shares tied to RSU vesting, and a grant of stock options for 42,553 shares at a $4.04 exercise price, expiring June 23, 2036.
What are the key terms of Chris Cleary’s new OBIO stock option grant?
Cleary received stock options covering 42,553 shares of Orchestra BioMed common stock at a $4.04 exercise price, expiring June 23, 2036. The options are scheduled to vest on the one-year anniversary of June 23, 2026, subject to continuous service.
How is the tax-withholding transaction for OBIO RSU vesting described?
The filing describes the 3,510-share disposition as withholding by the issuer to satisfy tax obligations from vesting restricted stock units. The footnote emphasizes that no shares were sold in the market in connection with this RSU vesting and tax withholding.
AI-generated analysis. How Rhea-AI works. Not financial advice.
